Dr. Mark Stewart discusses the role of the tumor mutational burden (TMB) in cancer research and the need for harmonization throughout the process.

For more information, please visit https://www.triconference.com/Companion-Diagnostics

Molecular Med Tri-Con 2019 | Real Precision Medicine is Starting with the Patient

The CHI Podcasts are produced by the Cambridge Healthtech Institute and offer in-depth interviews with research and business leaders from many facets of biotechnology.